![](/img/cover-not-exists.png)
Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the United States
Saab, Sammy, Parisé, Hélène, Virabhak, Suchin, Wang, Alice, Marx, Steven E., Sanchez Gonzalez, Yuri, Misurski, Derek, Johnson, ScottLanguage:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2016.1176030
Date:
April, 2016
File:
PDF, 1008 KB
english, 2016